drugset / Trial / NCT01728064
Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to examine the effects of EPI-743 on visual function and neurologic function in patients with Friedreich's ataxia.
Timeline
- Start
- 2012-12-31
- Primary completion
- 2015-10-31
- Completion
- 2016-02-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Vatiquinone | Small molecule | 200 mg | — |
| Comparator | Vatiquinone | Small molecule | 400 mg | — |